Observational studyDiabetes, obesity & metabolism2019

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.

Kåre I Birkeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.